The FTSE Finish Line: July 29 - 2025

Patrick Munnelly, Partner: Market Strategy, Tickmill Group.

London's stock indexes displayed mixed performance on Tuesday as investors digested a range of corporate updates and the implications of the newly signed U.S.-EU trade agreement. The FTSE 100, an international benchmark, edged higher, while the midcap FTSE 250, which focuses on domestic companies, declined. Healthcare stocks led sectoral gains, rising 1.8%, driven by AstraZeneca's 2.8% surge following second-quarter revenue and profit figures that exceeded expectations. Conversely, chemical stocks fell 2.5%, with Croda International plunging 5.1% after reporting disappointing first-half sales. Industrial miners also faced pressure, losing 1% amid falling copper prices, which contributed to declines of 2.4% for Glencore and 1.2% for Anglo American.

Meanwhile, a recent survey revealed that shop prices in Britain rose at their fastest pace in over a year in the 12 months leading up to July, with food prices seeing notable increases. The Bank of England is expected to cut borrowing costs on August 7, marking the fifth reduction since August of last year. Investors are also weighing the impact of a new 15% tariff on most goods imported from the European Union, a significant hike compared to pre-2025 levels. Ahead of the August 1 tariff deadline, U.S. President Donald Trump announced plans to implement a "world tariff" of 15% to 20% on trading partners that do not engage in separate trade negotiations with the U.S. Meanwhile, senior economic officials from the U.S. and China continued trade talks in Stockholm for a second day, seeking to resolve ongoing disputes and extend the current tariff ceasefire for an additional three months.

Single Stock Stories & Broker Updates:

  • AstraZeneca's shares increased by as much as 1.9% to 11,000p. The company surpassed profit expectations for Q2 and continues to uphold its revenue and core EPS forecasts for the full year. Jefferies anticipates that the limited impact of foreign exchange could lead to potential profit upgrades of around 2% in consensus. So far this year, AZN has risen approximately 4%, lagging behind the FTSE 100 index, which has gained about 11%.

  • Card Factory shares rise 9.2% to 97p, marking the largest intraday gain since December 2024. The company reports mid-single digits year-over-year sales growth for the five months ending June 30 and maintains expectations for mid-to-high single-digit sales growth and adjusted profit before tax in FY26. It plans to acquire funkypigeon.com for £24 million (~$32 million), expecting the purchase to boost earnings for the fiscal year ending January 31, 2027. Year-to-date, CARDC is down 2.8%.

  • Shares of Greggs down 2% at 1,612p; reports 14% fall in first-half profit, citing challenging market footfall and weather disruptions. Reiterates FY25 cost inflation guidance of around 6%; stock down ~40% YTD.

  • Shares of Forterra, a manufacturer of building products, have risen by 9.1%, reaching 200.5 pence. The stock is the leading performer in the FTSE All Share Index, which has increased by 0.2%. If these gains persist, this would mark the company's largest one-day percentage increase since November 2020. The company anticipates that its adjusted EBITDA for the second half will be slightly higher than the first half, and has reported a 82.4% year-over-year increase in adjusted profit before tax for the first half. According to Peel Hunt, the company is well-positioned for considerable improvements in profitability as volumes start to recover. Including today's movements, FORT stock has risen nearly 23% year-to-date.

Technical & Trade View

FTSE Bias: Bullish Above Bearish below 8700

  • Primary support 8600

  • Below 8500 opens 8400

  • Primary objective 9200

  • Daily VWAP Bullish